GNAS and pancreatic intraductal papillary-mucinous neoplasm: One of these 6 patients harbored a GNAS mutation (1/6, 17%), while 16 of the remaining 22 IPMN patients without nerve invasion harbored GNAS mutations (16/22, 73%).